ArticleJournal of clinical epidemiology2026
Quantifying new threats to health and biomedical literature integrity from rapidly scaled publications and problematic research.
Article in Journal of clinical epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Redundant pharmacovigilance disproportionality analyses: Navigating between Scylla and Charybdis.Headache · 2026Article
- Congenital malformations and medication exposures: Lack of data or lack of concern?British journal of clinical pharmacology · 2026Article
- TOP 2025: An update to the Transparency and Openness Promotion Guidelines.Research integrity and peer review · 2026Article
- Forty years of changes in scientific publishing: from conflict of interest to generative AI.Health affairs scholar · 2026Article
- Perspectives from the new co‑Editor‑in‑Chief of Population Health Metrics.Population health metrics · 2026Article
- Journal of Global Health's GUidelines for Authors on Requesting and DIsclosing changes in Authorship Nominations (GUARDIAN).Journal of global health · 2026Article
- Target trial emulation: bridging observational studies and randomized trials for health decision-making.Journal of comparative effectiveness research · 2026Article
- Using AI to improve peer review and research integrity in scientific journals.Health affairs scholar · 2026Article
- Association between air pollution, multimorbidity and polypharmacy: a systematic review and meta-analysis.BMJ public health · 2026Article
- Setting the standard for high-quality studies using open health datasets.PLoS medicine · 2025Article
- Navigating physical activity research in complex terrains: Reflections on the challenges, opportunities, and future directions.Journal of sport and health science · 2025Article
- Gold standard research-reflections on the NIH announcement.Health affairs scholar · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
BACKGROUND AND
objectivesThe last 3 years have seen an explosion in published manuscripts analyzing open-access health datasets, in many cases presenting misleading or biologically implausible findings. There is a growing evidence base to suggest that this is due in part to artificial intelligence-assisted and formulaic workflows, and publishers are responding by discouraging submissions employing open-access health datasets.
methodsHere we use a scientometric analysis to investigate which datasets have seen publication rates deviate from previous trends, especially where this coincides with changes to author geographical origins and increases in formulaic titles.
resultsAcross 36 datasets, we identify nine showing hallmarks of paper mill exploitation (FDA Adverse Event Reporting System, National Health And Nutrition Examination Survey, UK Biobank, FinnGen, the Global Burden of Disease Study, Medical Information Mart for Intensive Care, China Health and Retirement Longitudinal Study, Centers for Disease Control and Prevention Wide-ranging Online Data for Epidemiologic Research, and TriNetX). These nine datasets had, in 2025, a combined publication count of 23,005 indexed in the OpenAlex database. This represents an excess of 11,577 publications above the AutoRegressive Integrated Moving Average forecast trend, and is a 3.0×-fold change on the 7655 publication count for these nine datasets in 2022. We also identified a notable difference in the fold change for China (4.2×) vs. the rest of the world (1.9×) and an increase in formulaic titles.
conclusionThese findings highlight potential risks to research integrity in areas such as public health and drug safety, and especially to the accessibility and interoperability principles central to Open Science and Findable, Accessible, Interoperable and Reusable data practices. We argue that permissive open-access data policies naturally facilitate exploitative workflows and that these findings add to the case for the safeguarding mechanisms to preserve the goals of Open Science.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.